Clinical Trial Update: Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on the safety and efficacy of a neoantigen-based personalized immunotherapy used as consolidation therapy after standard adjuv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Neoantigen-based personalized immunotherapy

Snippet

Sponsor: Ying Yuan, MD | Conditions: CRC (Colorectal Cancer), Non Small Lung Cancer | Phase 1 | Status: COMPLETED